Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells
Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative autoimmune disorder of the central nervous system characterized by demyelination and neurodegeneration. Traditionally considered a T-cell-mediated disease, the crucial role of B lymphocytes in its pathogenesis, through different mechanisms contributing to inflammation and autor...
Alternative Titles
Full title
Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7cc4d1e57f054ae68572bf9e9d108d7b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7cc4d1e57f054ae68572bf9e9d108d7b
Other Identifiers
ISSN
2073-4409
E-ISSN
2073-4409
DOI
10.3390/cells14080606
